Vol 7 Issue 5

CELL AND GENE THERAPY INSIGHTS

Vol 7 Issue 5

Cell and Gene Therapy Insights Vol 7 Issue 5

Download PDF

Featuring

Issue Spotlight: Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success
Other articles
Webinars

Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success

Innovator Insight

Navigating regulations: novel cell therapy platforms and their path to clinical manufacturing

Navigating regulations: novel cell therapy platforms and their path to clinical manufacturing

N Bauer, N Calhoun, A Davies et al.

CMC obstacles in cell and gene therapy: four solutions to solve six challenges

CMC obstacles in cell and gene therapy: four solutions to solve six challenges

Subbu Viswanathan, Marc Puich

Commentary

Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy

Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy

Marcelo Bravo, Timothy J Davies, Paul J Fairchild

Viewpoint

Allogeneic T-cell therapies: from R&D lab to production facility

Allogeneic T-cell therapies: from R&D lab to production facility

Jakob Dupont, M.D., Joe Newell

Interview

Pursuing a fully closed cellular immunotherapy manufacturing model

Pursuing a fully closed cellular immunotherapy manufacturing model

Optimizing manufacturing processes to develop novel cell and gene therapies

Optimizing manufacturing processes to develop novel cell and gene therapies

Reflecting upon the GSK–UCL collaboration on viral vector bioprocess economics for ex vivo gene therapy commercialization

Reflecting upon the GSK–UCL collaboration on viral vector bioprocess economics for ex vivo gene therapy commercialization

Suzanne S Farid

A bright commercial future for off-the-shelf NK cell therapy

A bright commercial future for off-the-shelf NK cell therapy

Jan Spanholtz, Troels Jordansen, Volker Huppert

Journal articles

Editorial

Alternative strategies for functionalizing CAR-T cells: engineering without genetic modification

Alternative strategies for functionalizing CAR-T cells: engineering without genetic modification

Innovator Insight

Supporting development of mRNA-based therapies by addressing large-scale purification challenges

Supporting development of mRNA-based therapies by addressing large-scale purification challenges

FastFacts

Overcoming challenges of rapid stem cell expansion

Overcoming challenges of rapid stem cell expansion

Interview

Finishing strong: evolving fill and finish technology for the cell and gene therapy field

Finishing strong: evolving fill and finish technology for the cell and gene therapy field

Jean-Sebastien Parisse

From first collection to commercial launch: Streamlining your supply chain to support next generation therapies

From first collection to commercial launch: Streamlining your supply chain to support next generation therapies

Chris McClain, Aileen Baquiran

Applying Warp Speed lessons to your ATMP manufacturing facility

Applying Warp Speed lessons to your ATMP manufacturing facility

J P Bornholdt, C Heffernan, T Page et al.

Navigating regulations - novel cell therapy platforms and their path to clinical manufacturing

Navigating regulations - novel cell therapy platforms and their path to clinical manufacturing

N Bauer, N Calhoun, A Davies et al.

Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Y Ji PhD, S Ensari PhD, N Moore PhD

Accelerating CAR-T process development: The power of process insight

Accelerating CAR-T process development: The power of process insight

Julia Hupfeld PhD